Modified Shuyu Pills regulate VTA-NAc circuit myelination to ameliorate depressive behaviors in mouse model of vascular dementia via LDLR/MEK/ERK signaling pathway.
10.19540/j.cnki.cjcmm.20250306.401
- Author:
Song JING
1
;
Zi-Hu TAN
2
;
Qiong YANG
1
Author Information
1. Hubei University of Chinese Medicine Wuhan 430065, China.
2. Hubei University of Chinese Medicine Wuhan 430065, China Hubei Provincial Hospital of Traditional Chinese Medicine Wuhan 430061, China.
- Publication Type:Journal Article
- Keywords:
LDLR/MEK/ERK;
Modified Shuyu Pills;
VTA-NAc;
depressive behavior;
myelination;
vascular dementia(VaD)
- MeSH:
Animals;
Male;
Drugs, Chinese Herbal/administration & dosage*;
Mice;
Ventral Tegmental Area/metabolism*;
Mice, Inbred C57BL;
Disease Models, Animal;
Depression/genetics*;
Receptors, LDL/genetics*;
Dementia, Vascular/psychology*;
MAP Kinase Signaling System/drug effects*;
Nucleus Accumbens/metabolism*;
Behavior, Animal/drug effects*;
Humans;
Myelin Sheath/drug effects*;
Extracellular Signal-Regulated MAP Kinases/genetics*
- From:
China Journal of Chinese Materia Medica
2025;50(16):4555-4563
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to explore the effects and potential mechanisms of Modified Shuyu Pills in ameliorating depressive behaviors in the mouse model of vascular dementia(VaD). Seventy-two three-month-old male C57BL/6 mice were assigned into six groups: sham, model, low-, medium-, and high-dose Modified Shuyu Pills, and fluoxetine. The other five groups except the sham group underwent bilateral common carotid artery stenosis combined with chronic unpredictable stress. Depressive behaviors were assessed by the sucrose preference test and tail suspension test. Cerebral blood flow was measured by laser speckle imaging. Protein levels of low density lipoprotein receptor(LDLR), mitogen-activated protein kinase kinase(MEK), phosphorylated(p)-MEK, extracellular signal-regulated kinase(ERK), and p-ERK in the ventral tegmental area(VTA) and nucleus accumbens(NAc) were determined by Western blot. The fluorescence intensity of myelin basic protein(MBP) in the VTA and NAc were measured by immunofluorescence. Myelin sheath morphology in the VTA and NAc was observed by luxol fast blue staining, and the ultrastructure of myelin sheath in the VTA and NAc was examined by transmission electron microscopy. In the tail suspension test, the immobility time of the model group was longer than that of the sham group(P<0.01). In the sucrose preference test, the sucrose preference rate of the model group was lower than that of the sham group(P<0.01). After intervention with Modified Shuyu Pills, the immobility time in the tail suspension test was shortened(P<0.01), and the sucrose preference rate increased(P<0.01). Laser speckle imaging results showed that compared with the sham group, the model group showed reduced cerebral blood flow(P<0.01), and the reduction was reversed by medium-and high-dose Modified Shuyu Pills(P<0.01). Western blot results indicated that the relative expression levels of LDLR, p-MEK/MEK, and p-ERK/ERK in the VTA and NAc of the model group were lower than those in the sham group(P<0.01). Medium-and high-dose Modified Shuyu Pills reversed this trend(P<0.01). Immunofluorescence results showed that the fluorescence intensity of MBP in the VTA and NAc of the model group was lower than that of the sham group(P<0.01). The medium-and high-dose Modified Shuyu Pills groups showed increased fluorescence intensity of MBP in the VTA compared with the model group(P<0.01). In the NAc, the fluorescence intensity of MBP in all the groups of Modified Shuyu Pills increased to varying degrees compared with that in the model group(P<0.01). Luxol fast blue staining results showed that the model group presented lighter staining intensity and looser arrangement of myelin fibers than the sham group, indicating significant demyelination in the model group. However, after intervention with medium-and high-dose Modified Shuyu Pills, the staining intensity and myelin sheath structure in the VTA and NAc were improved. Transmission electron microscopy results revealed that the myelin sheath in the VTA and NAc of the sham group was intact and dense, while the model group exhibited extensive myelin loss, with myelin sheath degeneration and disintegration. After intervention with Modified Shuyu Pills, the myelin sheath loss in the VTA and NAc of mice was reduced, and the proportion of myelinated tissue increased. In summary, Modified Shuyu Pills may promote myelination via the VTA-NAc circuit by upregulating the LDLR/MEK/ERK signaling pathway, thereby ameliorating depressive-like behaviors in VaD mice.
